Lawyers are now filing claims for those who suffered vaso-occlusive crisis or death after taking the SCD drug Oxbryta.
Those who have suffered the following complications may be entitled to substantial compensation:
Pfizer’s drug Oxbryta was approved in 2019 as a novel approach to treat Sickle Cell Disease by attacking the primary cause of the disorder. At the time, it held such promise that it was granted accelerated FDA approval.
Unfortunately, patients were left shocked when the drug was abruptly removed from the market in 2024 after studies showed it could actually increase the risk of severe Sickle Cell complications or death.
On September 25, 2024, Pfizer announced it would remove Oxbryta from the market, stop distribution, and discontinue all ongoing clinical trials worldwide.
The decision came after two separate clinical studies showed those with sickle cell disease taking Oxbryta had a higher rate of vaso-occlusive crisis (restriction of oxygen and blood flow to tissue), as well as death.
Oxbryta has been prescribed to tens of thousands of patients as young as 4 years old in recent years. Therefore, doctors fear thousands of children and adults may have suffered severe side effects or death. Also, new reports indicate Pfizer may have continued to sell the drug while knowing the dangers.
If you or a loved one suffered vaso-occlusive crisis or death after using Oxbryta, it’s important to learn about your legal rights. Contact us today to speak directly with a lawyer.
Latest Information on the Oxbryt Litigation
No. Lawyers expect thousands of victims will eventually file lawsuits against Pfizer for worsening sickle cell complications or death from the drug Oxbryta. However, claims are likely to be consolidated into a special multidistrict litigation court rather than a Class Action Lawsuit.
In order to handle the volume of cases most efficiently, lawsuits alleging similar injuries from one product like Oxbryta are often consolidated into specific courts like these.
Instead of forcing people into a single class action lawsuit for Oxbryta injuries, multidistrict litigation (MDL) courts allow victims to band their individual cases together in a special court to seek damages against Pfizer.
This MDL process can be more advantageous for victims than a class action lawsuit. In a class action, lawyers gather class participants together who then share whatever is awarded. However, individual participants in an MDL select their own lawyer, have more control over their case and whether it settles, and reap higher award amounts for their separate lawsuit.
DrugNews works only with lawyers that have handled thousands of defective drug and medical device injury cases and are integrally involved with MDL litigation and courts.
If you or a loved one have suffered vaso-occlusive crisis (VOC), stroke, organ damage or death after taking the drug Oxbryta, it’s important to have your case examined by a legal expert to see if you have the right to recover damages.
Our qualified pharmaceutical injury lawyers will fully investigate your case, reviewing medical records, safety warnings and recent studies that your doctor may not normally discuss.
Most states allow you several years to file a lawsuit after you suffer an injury or discover it may be linked to a dangerous product. However, you should begin the process as early as possible to make sure your lawyer has time to get necessary records and prepare your case.
DrugNews works only with attorneys and law firms that have successfully handled tens of thousands of lawsuits involving injury or death from drugs and medical devices. And, you can speak directly with a lawyer or patient advocate today, so you’ll be able to decide if you want to proceed.
We make it easy to get help, find out if you qualify, and quickly file a claim. Our service is offered at no cost to you, and you won't pay anything to your attorney unless you receive an award. Also, our qualified lawyers can handle most aspects of your case without you ever having to leave your home.
For more information, or to learn about your options - call, chat or email us today.
Call, email or live chat with us today to see how we can help.
